Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 117 for neurosurgery

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Evaluating Optic Nerve Disease with OCT Angiography

    Rochester, MN

  2. Magnetic Resonance Elastography of Dementia

    Rochester, MN

  3. A Study to Collect Blood DNA Samples from Patients with Clinically Diagnosed Alzheimers Disease, Lewy Body Disease, and Frontotemporal Degeneration

    Rochester, MN

  4. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)

    Jacksonville, FL, Rochester, MN

  5. Creation of PLACENTA/Serum Repository Database: Autoimmunity from Mother To Baby Study

    Rochester, MN

  6. A Study to Investigate Biomarkers for Phenotyping of Neurodegenerative Disorders

    Jacksonville, FL

  7. Stem Cells from Skin Fibroblasts in Patients with Hereditary Peripheral Neuropathy

    Rochester, MN

  8. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

    Rochester, MN

  9. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)

    Rochester, MN

  10. Brain Health and Dementia Prevention Registry

    Jacksonville, FL

.

Mayo Clinic Footer